Insuman Comb 15 (Insulin Human (Rdna))

• Insuman Comb 15, a premixed insulin preparation, is used in the management of diabetes mellitus to achieve glycemic control.
• Type 1 diabetes mellitus: provides basal and prandial insulin coverage to maintain target blood glucose.
• Type 2 diabetes mellitus: assists in achieving glycemic targets when oral agents are insufficient.
• Adjunct to diet and exercise in diabetes management: helps achieve glycemic goals when lifestyle measures alone are inadequate.

• Insulin human binds to insulin receptors on muscle, adipose and hepatic cells, activating intracellular signaling pathways that promote glucose uptake, glycogen synthesis and lipogenesis while suppressing hepatic glucose production. The premixed formulation combines rapid‑acting soluble insulin for post‑prandial control with intermediate‑acting isophane (NPH) insulin to provide basal coverage.

Insuman Comb 15 may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

• Hypoglycemia: symptoms of low blood glucose such as sweating, tremor, or confusion.
• Injection site reactions: redness, swelling or itching at the injection site.
• Weight gain: modest increase in body weight due to improved glucose utilization.
• Lipodystrophy: localized changes in fat tissue at injection sites.

Serious or Rare Side Effects

• Severe hypoglycemia: can lead to seizures, loss of consciousness, or injury.
• Allergic reactions: including rash, urticaria, or anaphylaxis.
• Insulin edema: fluid retention causing swelling, particularly in the lower extremities.

• When using Insuman Comb 15, several precautions should be observed to ensure safe and effective therapy.
• Dose adjustment: tailor the dose based on regular blood glucose monitoring and clinical response.
• Hypoglycemia risk: educate patients on recognizing and treating low blood glucose episodes.
• Renal impairment: monitor kidney function and consider dose reduction if needed.
• Pregnancy: use only if the potential benefit justifies the potential risk; consult a healthcare professional.
• Driving and operating machinery: avoid activities that require full alertness if hypoglycemia is likely.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 15 can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Beta‑blockers: may mask hypoglycemia symptoms.
• Sulfonylureas or meglitinides: increase risk of severe hypoglycemia.
• Glucocorticoids: may require higher insulin doses.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: can potentiate insulin’s glucose‑lowering effect.
• Thiazide diuretics: may raise blood glucose levels.
• Alcohol: can cause delayed hypoglycemia, especially with missed meals.